Universal Health beats Q2 revenue estimates. cuts FY profit view
Reuters2026/07/27 20:25
Overview
U.S. hospital operator's Q2 revenue rose 8.3%, beating analyst expectations
Adjusted EPS for Q2 rose to $5.98
Company repurchased 1.89 mln shares for $320.3 mln in Q2
Outlook
Universal Health revises 2026 net revenue forecast to $18.501 bln-$18.762 bln, slightly higher than prior forecast
Company now sees 2026 adjusted EBITDA, net of NCI, at $2.610 bln-$2.717 bln, lower than prior forecast
Universal Health expects 2026 adjusted EPS-diluted of $22.28-$23.65, lower than earlier forecast
Result Drivers
ACUTE CARE GROWTH - Co said same-facility acute care hospitals saw adjusted admissions rise 2.9% and net revenue per adjusted admission increase 3.0% in Q2
BEHAVIORAL HEALTH REVENUE - Co said same-facility behavioral health facilities saw net revenue per adjusted admission rise 7.1% in Q2
MEDICAID PROGRAM IMPACT - Q2 results included a $100 mln favorable pre-tax impact from the Florida Medicaid managed care directed payment program
Company press release: ID:nPn5TDzZpa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$4.64 bln |
$4.58 bln (15 Analysts) |
Q2 EPS |
|
$5.98 |
|
Analyst Coverage
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 7 "strong buy" or "buy", 14 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities services peer group is "buy."
Wall Street's median 12-month price target for Universal Health Services Inc is $202.00, about 29.7% above its July 24 closing price of $155.75
The stock recently traded at 6 times the next 12-month earnings vs. a P/E of 7 three months ago
Reuters Recommended Reads
July 27 - Ensign Group Q2 profit beats on higher occupancy rates
July 27 - Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO
July 27 - AstraZeneca drug prices evolving in response to Trump policy, executive says
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3 Altcoins Set to Shine in 2026: Top Picks, Catalysts, and Market Trends

World Gold Council’s Bitcoin zero forecast tested as price holds near $63,000
Hackers exploited macOS Screen Sharing flaw to install Monero miners, Dutch cyber agency says
3 Altcoins With Major Catalysts and Risks to Watch in 2026
